Although many general anesthetics have been found to produce anesthetic and analgesic effects by augmenting GABA A receptor (GABA A R) function, the role of the glycine receptor (GlyR) in this process is not fully understood at the neuronal level in the spinal cord. We investigated the effects of a barbiturate general anesthetic, pentobarbital (PB), on the glycinergic miniature inhibitory postsynaptic currents (mIPSCs) and the responses to exogenously applied glycine, or taurine, a low affinity GlyR agonist, by using the whole-cell patchclamp technique in the rat spinal dorsal horn neurons isolated using a novel mechanical method. Bath application of 30 M PB significantly prolonged the decay time constant of the spontaneous glycinergic mIPSC without changing its amplitude and frequency. Coapplication of 0.3 mM PB reduced the peak amplitude, affected the macroscopic desensitization and deactivation of the response to externally applied Gly in a concentration-dependent manner. In addition, the recovery of Gly response from desensitization was also prolonged by PB. However, PB did not change the desensitization and deactivation kinetics of the taurine-induced response. The GABA A R antagonist bicuculline (10 M) did not affect the effect of PB on the Gly response. Thus, PB prolonged the spinal glycinergic mIPSCs by slowing desensitization and deactivation of GlyR. Two other structurally different intravenous anesthetics, i.e. propofol (10 M) and etomidate (3 M), prolonged the duration of the glycinergic mIPSC in the rat spinal dorsal horn neurons. In conclusion, on GlyR-Cl ؊ channel complexes there may exist action site(s) of intravenous general anesthetics. GlyR and glycinergic neurotransmission may play an important role in the modulation of general anesthesia in the mammalian spinal cord.
trophysiological studies have shown that all of these drugs mimic and/or potentiate the inhibition mediated by the GABA A 1 receptor (GABA A R) in the brain and that their potency and efficacy in exerting GABA-like and/or GABA-potentiating actions correlate with their abilities to induce anesthesia (2) . These observations support the notion that GABA A R plays an important role in general anesthesia.
The glycine receptor (GlyR), like GABA A R-Cl Ϫ channel complexes, is another major inhibitory receptor in the adult mammalian spinal cord and brain stem (3) . Although GlyR and GABA A R are highly homologous in both structure and function, we know much less about the effects of general anesthetics on GlyR than on GABA A R. Recently, several lines of evidence have indicated that GlyR is positively modulated by volatile ether and alkanes, n-alcohols and chloral derivatives (4) but is much less sensitive to the barbiturates, propofol and etomidate (ET) (2) .
One approach to understanding the receptor mechanisms of the general anesthetics is to investigate the anesthetic-induced modulation of receptor desensitization and deactivation. The general anesthetic propofol (5, 6) , the volatile anesthetic halothane (7) , as well as the neurosteroid 3␣-21-dihydroxy-5␣-pregnan-20-one (THDOC) (8) and pregnenolone sulfate (9) have been observed to affect GABA A R deactivation and/or desensitization. However, little information is available for the effects of general anesthetics on GlyR kinetics. On the other hand, a piece of evidence has shown that the anesthetic targets involved in the suppression of movement in response to noxious stimuli may lie in the spinal cord (10 -12) , where glycine is known to be a key transmitter. In the present study we investigated the modulation of a hypnotic-anesthetic barbiturate, pentobarbital (PB), on the glycinergic miniature inhibitory postsynaptic currents (mIPSCs) as well as GlyR desensitization and deactivation in the acutely dissociated rat spinal dorsal horn neurons. Knowing that PB significantly prolonged the duration of the glycinergic mIPSCs and affected the kinetics of GlyR, we further examined the effects of two other widely applied intravenous general anesthetics, propofol and ET, on 1 The abbreviations used are: GABA, ␥-aminobutyric acid; AP-5, 2-amino-5-phosphonovaleric acid; BMI, bicuculline; CNQX, 6-cyano-7-nitroquinoxalne-2,3-dione; ET, Etomidate; GABA A R, GABA type A receptor; GlyR, glycine receptor; I f , the amplitude of the fast component; I Gly , glycine-induced currents; I (GlyϩPB) , the current amplitude evoked by the Gly pulse in the presence of PB; I PB , PB-evoked current; I s , the amplitude of the slow component; mIPSCs, miniature inhibitory postsynaptic currents; K-S test, Kolomogorov-Smirnov test; PB, pentobarbital; Tau, taurine; TEA, tetraethylammonium; THDOC, 3␣-21-dihydroxy-5␣-pregnan-20-one; TTX, tetrodotoxin. f , the desensitizing time constant of fast component; s , the desensitizing time constant of slow component; des , time constant of desensitization; ANOVA, analysis of variance. the glycinergic mIPSCs. The present results suggest that on the GlyR-Cl Ϫ channel complexes action site(s) of intravenous general anesthetics may exist, through which intravenous general anesthetics augment the spinal inhibitory neurotransmission by slowing the desensitization and deactivation of the GlyR.
EXPERIMENTAL PROCEDURES
Isolation of Neurons-The care and use of animals used for these experiments followed the guidelines and protocols approved by our institutional Animal Care and Use Committee. Wistar rats (2-week-old) were anesthetized with urethane (1 g/kg, intraperitoneal). The acutely dissociated rat dorsal horn neurons attached with intact glycinergic presynaptic terminals were mechanically dissociated as described previously (13, 14) . In brief, rats were sacrificed by decapitation, and the transverse slices (400 m) of spinal cord were sectioned using a vibrotome tissue slicer (VT1000S, Leica instruments Ltd, Wetzlar, Germany). After incubated at room temperature (22-25°C) for 50 min in an incubation solution aerated with 95% O 2 ϩ 5% CO 2 , the slices were transferred into standard external solution. A vibration-isolation system (15) was then used to mechanically dissociate the dorsal horn neurons. Fire-polished glass pipette mounted on a vibrator touched lightly and vibrated horizontally at about 5-10 Hz on the surface of the slice under the control of a pulse generator. The vibration-dissociation lasted for about 3 min, and then the slices were removed out of the dish. Isolated neurons attached to the bottom of the culture dish and were ready for electrophysiological experiments within 20 min. These neurons, which were dissociated without using any enzymes, retained some of their original morphological features including the proximal dendritic processes.
Electrophysiology-Whole-cell voltage-clamp recordings were made at room temperature (22-25°C). The 35-mm culture dish was used as the recording chamber, which was perfused at 0.5-2.0 ml/min with the standard external solution. Patch pipettes were pulled from glass capillaries (Narishige, Tokyo, Japan) with an outer diameter of 1.5 mm on a two-stage puller (PP-830, Narishige, Tokyo, Japan). The resistance between the recording electrode filled with pipette solution and the reference electrode was 4 -6 M⍀. The liquid junction potentials were 3-4 mV and were used to calibrate the holding potential. ET was provided by the laboratory of Anesthesia and CPB, Cardiovascular Institute of Fuwai, CAMS, China. ET was used in an aqueous formulation containing 35% propylene glycol diluted into normal external standard solution. Propofol was prepared from Diprivan (Zeneca Limited, Macclesfield, Cheshire, UK). Each milliliter of Diprivan contains 10 mg of propofol. The vehicle contains glycerol, soybean oil, purified egg phosphatide/egg lecithin, sodium hydroxide, and water. Intralipid, at concentrations equivalent to those used in the previous experiments, did not alter the actions of propofol (5) . Other drugs used in the present experiments were from Sigma and first dissolved with ion-free water and then diluted to the final concentrations in the standard external solution just before use. Drugs were applied using a rapid application technique termed the "Y-tube" method throughout the experiments (16) . This system allows a complete exchange of external solution surrounding a neuron within 20 ms.
Data Analysis-Mini Analysis Program (version 4.3.3, Synaptosoft Inc.) was used to analyze mIPSCs. The Kolmogorov-Smirnov test (K-S test) was used to assess differences in mean values of mIPSCs from different conditions. Decay kinetics was measured as the time for the mIPSCs to decay to 37% of its peak amplitude. Current deactivation and desensitization were fitted by exponential functions, beginning shortly after the peak of response (Clampfit 8.0, Axon Instruments, Foster City, CA). Curve fitting was performed by using simplex algorithm least-squares exponential fitting routines with single or double exponential equations of the form I(t) ϭ I f exp(-t/ f ) ϩ I s exp(-t/ s ), where I f and I s are the amplitudes of the fast and slow components, and f and s are their respective time constants. % f was calculated according to the formula: % f ϭ I f /(I f ϩ I s ). To compare desensitization times between different exponential conditions, we used a weighted time constant
Fitting the deactivation trace began from the peak of the tail current when the tail current appeared, otherwise the fit began from the removal of drug(s). Recovery from desensitization was assessed using a paired-pulse protocol (8, 17) . The percentage recovery, defined as ((peak 2 Ϫ onset 2 )/(peak 1 Ϫ onset 1 )) ϫ 100, is plotted as a function of interpulse interval and fitted to a monoexponential function. Origin (Microcal Software) and Excel (Microsoft, Seattle, WA) were used for data display and analysis. Statistical comparison was carried out using Student's t test for two groups' comparison and analysis of variance (ANOVA) for multiple comparison (as noted) with p Ͻ 0.05 (*) or 0.01(**) considered significant (n ϭ number of cells). NS indicates no statistical significance. All values represented the means Ϯ S.E. of the mean (S.E.).
RESULTS

PB Prolongs the Duration of Glycinergic mIPSCs in Dorsal Horn
Neurons-Neurons were mainly dissociated from the deep dorsal horn including the sacral dorsal commissural nucleus (13, 16) . Most of the neurons were medium-sized (10 -15 m in diameter) with oval or triangular soma and 1-3 apical stem dendrites. Whole-cell recordings were obtained from these spinal dorsal horn neurons attached with intact glycinergic presynaptic terminals (13, 14) . Stable recordings could be made for up to 2 h. Most neurons (97 of 121) evaluated exhibited mIPSCs at a holding potential of Ϫ50 mV.
The glycinergic mIPSCs were recorded in the presence of CNQX (3 M), D-AP5 (10 M), BMI (10 M), and TTX (0.3 M). Superfusing 30 M PB significantly prolonged the duration of glycinergic mIPSCs (Fig. 1) . The decay time course of the mIPSCs was markedly increased to 156 Ϯ 5% of the control ( control ϭ 16.7 Ϯ 2.7 ms; PB ϭ 25.7 Ϯ 3.8 ms; n ϭ 9, p Ͻ 0.01, Student's paired t test). However, neither the amplitude nor 
FIG. 3. Effect of PB (0.3 mM) on GlyR desensitization. A, left, I
Gly desensitized along a bi-exponential; middle, I Gly in the presence of PB; right, currents recorded before and after the co-application of Gly and PB were normalized to peak amplitude for comparison of the time courses of I Gly desensitization. B, summary of the percentage changes of I Gly produced by PB (n ϭ 12). Amp is the peak amplitude; is the desensitization time constant of the I Gly . f and s are the fast and slow desensitization time constants of the I Gly in the presence of PB. S/P is the ratio between the amplitude at 15 s (S) and peak amplitude (P), and % f is the relative contribution of the fast desensitization component. Each bar represents the mean Ϯ S.E. Arrowhead indicates the "rebound" current that appears after the washout of the agonist. * indicates significant difference from control, p Ͻ 0.05 (Student's paired t test).
the frequency of the mIPSC were significantly affected by 30 M PB (Fig. 1D) .
Effect of PB on I Gly -The effect of PB at clinically relevant concentrations (0.1-0.4 mM) on Gly-induced current (I Gly ) was investigated in the following experiment. In contrast to the observation that the PB increases the peak amplitude of the GABA-induced current in the same preparation (13, 18) , no increase in the I Gly amplitude was observed in the presence of 0.3 mM PB. Instead, PB (0.3 mM) inhibited the peak I Gly significantly (Fig. 2) . Meanwhile, the I Gly desensitization was facilitated in the presence of PB. Fig. 2 illustrates the ratio of the current amplitude evoked by the Gly pulse in the presence of PB (I (GlyϩPB) ) which was calculated according to the following formula: ratio ϭ (I (Gly ϩ PB) Ϫ I PB )/I Gly , where I PB represents the PB-evoked current. In the present preparation, 0.3 mM PB evoked a small (Ͻ100 pA) or no inward current. The inhibition of the peak I Gly in the presence of 0.3 mM PB did not show an obvious difference among distinct Gly concentrations while the ratio of change in I Gly desensitization increased in response to the raise in Gly concentrations. Alternatively, the alteration of GlyR desensitization by PB was dependent on the Gly concentrations.
Effect of PB on the I Gly Macroscopic Desensitization-To determine quantitatively the alteration of the desensitization kinetics of I Gly induced by PB, we applied 1 mM Gly for 15 s in the absence or presence of 0.3 mM PB. The co-application of Gly and PB was always preceded by the 15-s-long pretreatment of PB. I PB was not shown in the figures. Although the rate and extent of the I Gly desensitization were quite variable among cells, individual cell responses were consistent from one application to the next. The desensitization of the 1 mM I Gly could be accounted for with a bi-exponential fit (Fig. 3A) . The PB-induced variations of amplitude, fast and slow desensitization time constants, and % f of the I Gly desensitizing along bi-exponential were summarized in Fig. 3B . The changes in amplitude (14 Ϯ 1% of control, n ϭ 12), and fast and slow desensitization time constants (30 Ϯ 3 and 41 Ϯ 5%, respectively, n ϭ 12) were statistically significant (p Ͻ 0.05). In contrast, the changes of either the % f or the ratio between the amplitudes of the sustained (S) and peak (P) currents (S/P) were not (17 Ϯ 2% of control, p Ͼ 0.05, n ϭ 12; 15 Ϯ 8%, p Ͼ 0.05, n ϭ 12). Concurrently, the current noise was augmented in the presence of PB. When the I Gly was normalized and superimposed (Fig. 3A) , the acceleration of the desensitization by PB could be identified. In addition, the washout of Gly with PB co-application induced a transient inward current (rebound current) (Fig. 3A) .
We next tested whether the membrane potential influences the action of PB on I Gly desensitization. In the absence of PB, membrane depolarization was associated with an increase in the time constant of desensitization ( des ) (Fig. 4B) . des increased with increasing membrane potentials at a rate of e-fold/54 mV. PB significantly reduced des at all tested holding potentials. The change of des induced by PB increased with the increase in membrane potentials. In the presence of PB, des did not obviously change when the membrane potentials increased. The regression slope gave a voltage dependence of e-fold per 594 mV which was 10-fold slower than that of I Gly in the absence of PB (Fig. 4B) , indicating a significant difference between effects of PB on desensitization at symmetrical membrane potentials (Fig. 4C) (the reversal potential of I Gly was approximate 0 mV, data not shown). In addition, the amplitude depression of I Gly induced by PB was not influenced by membrane potential change (p Ͼ 0.05, n ϭ 5, one-way ANOVA) (Fig.  4C ). The rebound current appeared at all tested holding potentials.
Comparison of PB Effects on GlyR in Different Drug
Application Modes-To investigate the mechanism of PB's effect on GlyR desensitization, we applied different drug application modes on the same neurons. As shown in Fig. 5 , (Fig. 5Ac) , the weighted des was increased (1.25 Ϯ 0.09 of control, p Ͻ 0.05, n ϭ 8). The rebound current occurred with the first two application modes but not the third application mode. Therefore, PB might slow the desensitization of GlyR (see "Discussion").
PB Slows the I Gly Deactivation-A previous study (17) has shown that the rate of GABA A receptor (GABA A R) deactivation decreased in proportion to the extent of desensitization in the absence of anesthetics. The fact that PB accelerated the I Gly desensitization inspired us to examine the possible coupling of the I Gly desensitization and deactivation in the presence of PB.
The rates of the I Gly desensitization and deactivation in the presence of PB were found to be quite variable among cells. However, the change trend of individual cell responses induced by PB was consistent. As shown in Fig. 6A , preperfusion of PB at high concentrations (0.3 and 3 mM) evoked a visible current. A rebound current occurred after the washout of the co-application of 1 mM Gly and PB at high concentrations (0.3 or 3 mM). The inset of Fig. 6 shows representative superimposed rebound currents in one recording, for PB (0.03, 0.3, and 3 mM) and 1 mM Gly. The relative amplitude of the rebound current was increased with the raise of the concentrations of PB. In the presence of PB, the peak current of I Gly was significantly reduced (for three concentrations of PB, p Ͻ 0.05, Student's paired t test) (Fig. 6B) . The ratio of reduction was increased with the increase of the concentrations of PB. At a low concentration of PB (0.03 mM), the desensitization of I Gly was not affected (ratio of weighted , 1.05 Ϯ 0.09, p Ͼ 0.05, Student's paired t test). At higher concentrations, PB significantly accelerated the desensitization of I Gly (for 0.3 mM PB, ratio of weighted , 0.48 Ϯ 0.05, p Ͻ 0.05, Student's paired t test; for 3 mM PB, ratio of weighted , 0.41 Ϯ 0.10, p Ͻ 0.01, paired t test) (Fig. 6B) . The deactivation phase of I Gly in the presence of 0.03 mM PB was fitted by bi-exponential functions at the completion of the initial sigmoidal onset phase. PB (0.03 mM) significantly slowed the deactivation of I Gly . The time constants of fast ( f ) and slow ( s ) deactivating components were increased to 1.34 Ϯ 0.20 (p Ͻ 0.05, Student's paired t test) and 1.34 Ϯ 0.23 (p Ͻ 0.05, Student's paired t test), respectively (Fig. 6C) .
PB Slows the Recovery of I Gly from Paired-Pulse Desensitization-The recognition of the role of desensitization in prolonging GABA A R deactivation (17) leads to the hypothesis that anesthetics, which have slowed deactivation, might do so by slowing recovery from the desensitized state. To assess this possibility, previous investigators performed paired-pulse experiments and found that recovery from the GABA A R desensitization was delayed by these agents (6 -8) .
To characterize the recovery of the I Gly from desensitization, we used paired applications of Gly (1 mM, 10 s) on ten cells. The response after the first application of Gly had an obvious reduction in peak current (Fig. 7A) , suggesting that a fraction of channels may be desensitized during the first application. The recovery of channels from desensitization gradually increased with the interval increasing between Gly applications, and the recovery time course of desensitization extended over several seconds. Similar to the effects of barbiturates on GABA A R, the co-application of PB with Gly prolonged the interval of paired pulses required for the recovery of desensitized receptor chan- a, b, c) . B, summary of the ratio of amplitude and weighted des of I Gly with three application modes of PB and glycine demonstrated in A (n ϭ 8). ** and * indicate significant difference from control, p Ͻ 0.01 and 0.05 (Student's paired t test), respectively. nels (Fig. 7A) . In Fig. 7B , the average recovery of the response from desensitization plotted against the paired pulse interval illustrated that resensitization of the GlyR was slowed in the presence of 0.3 mM PB. Monoexponential fitting of the recovery showed an increase from 3.5 to 4.5 s for the recovery time constant in the presence of PB.
No Effect of PB on the Desensitization and Deactivation of Low Affinity Agonist
Response-For the low affinity agonists, such as taurine (Tau) and ␤-alanine, the unbinding rate is fast enough that the channel closing rate becomes the rate-limiting step for deactivation, which is extremely rapid after agonist withdrawal (7, 8, 19) . We took advantage of the very rapid unbinding kinetics of Tau to test whether PB altered the channel closing rate by measuring the current deactivation rate after a 15-s application of 1 mM Tau in the absence or presence of 0.3 mM PB (Fig. 8) . PB caused a decrease in the peak Tau current, but had no effect on the desensitization ( control / PB , 1.01 Ϯ 0.06, n ϭ 6; p Ͼ 0.05; Student's paired t test). The influence of PB on rapid deactivation of Tau current was also neglectable ( control / PB , 1.05 Ϯ 0.06, n ϭ 6; p Ͼ 0.05; Student's paired t test) (Fig. 8B) . Furthermore, the rebound current disappeared probably due to the rapid unbinding rate of Tau on GlyR. Similar to that observed for the co-application of PB and Gly, the noise of the Tau-activated current was augmented in the presence of PB.
Effect of PB on I Gly Is Independent of the Activation of GABA A R-To avoid the activation of GABA A R by PB, the antagonist of GABA A R, BMI (10 M), was coapplied with Gly and PB, which completely eliminated the PB-induced current. The effect of PB (0.3 mM) on 1 mM I Gly , however, was not signifi- FIG. 6 . Effect of PB on GlyR deactivation. A, sample recordings from the same cell illustrating the effect of PB on the kinetics of I Gly . The inset shows the tail currents caused by washout of different concentrations of PB plus 1 mM Gly were normalized to the amplitude at 15 s for comparison of the tail current amplitude and the time course of I Gly deactivation. i-iv correspond to the currents caused by the washout of 1 mM Gly, 1 mM Gly plus 0.03 mM, or 0.3 mM, or 3 mM PB, respectively. B, summary of the ratio of amplitude and weighted desensitization time constant of I Gly in the presence of PB at different concentrations to control (n ϭ 5). C, summary of the ratio of deactivation time constant of I Gly at the presence of 0.03 mM PB (n ϭ 6). Each column represents the mean Ϯ S.E. ** and * indicate significant difference from control, p Ͻ 0.01 and 0.05 (Student's paired t test), respectively. cantly influenced by BMI treatment. As shown in Fig. 9 , differences in the ratio to control of the peak amplitude of I Gly (0.85 Ϯ 0.05 to 0.86 Ϯ 0.07, n ϭ 5), the fast and slow desensitization time constants (0.70 Ϯ 0.11 to 0.71 Ϯ 0.08 and 0.58 Ϯ 0.10 to 0.60 Ϯ 0.07, respectively, n ϭ 5), as well as the fast and slow deactivation time constants (1.18 Ϯ 0.05 to 1.16 Ϯ 0.04 and 1.14 Ϯ 0.03 to 1.13 Ϯ 0.03, respectively, n ϭ 5) were not statistically significant between the two groups treated with or without BMI (p Ͼ 0.05, Student's paired t test). The variations of the I Gly amplitude and % f were also unaffected after BMI application.
Comparison of PB with Propofol and ET-The effects of two other structurally different intravenous anesthetics, propofol and ET (Fig. 10A) , on glycinergic mIPSCs were also studied. The decay time constants of the mIPSCs were markedly increased by 56 Ϯ 5% (n ϭ 9), 66 Ϯ 20% (n ϭ 7), and 47 Ϯ 20% (n ϭ 9) as compared with the control (p Ͻ 0.01, Student's paired t test) in the presence of 30 M PB, 10 M propofol, and 3 M ET, respectively (Fig. 10, B and C) . The frequency of the glycinergic mIPSCs was not significantly affected by these three intravenous general anesthetics (Fig. 10C) . In addition, propofol augmented the amplitude of the glycinergic mIPSC.
DISCUSSION
In the present study, we demonstrated that the general anesthetics PB, propofol and ET all prolonged the duration of mIPSCs in the rat spinal dorsal horn neurons. Furthermore, PB slowed GlyR desensitization and deactivation, which might in turn result in the prolongation of the glycinergic mIPSCs.
Spinal GlyR as An Important Target for General Anesthetics-The relevant components of anesthesia (amnesia, analgesia, unconsciousness, and immobility in response to a noxious stimulus) have traditionally been thought to be the result of anesthetic action in the brain. However, recent evidence seems to provide support for a spinal control of anesthesia (10 -12) . In addition, anesthetics could act on the site of brain for amnesia and unconsciousness by decreasing the transmission of noxious information from the spinal cord to the brain (20) . Thus, the spinal cord is an important site of anesthetic action in suppression of movement in response to noxious stimuli (21) (22) (23) .
Spinal sensory processing and its ascending transmission are under local tonic inhibitory control which is largely mediated by the inhibitory amino acid receptors, GABA A R and GlyR. Current available evidence, however, suggests that the potential role of the GlyR in clinical anesthesia is likely to be restricted to the mediation of an aspect of volatile anesthetic action (2, 24, 25) . The present results clearly show that three classic intravenous general anesthetics, PB, propofol, and ET, all prolonged the duration of the glycinergic mIPSCs in the rat spinal dorsal horn neurons. Previous studies have shown that the prolongation of IPSCs duration primarily reflects receptor gating and the unbinding of agonist rather than diffusion of transmitter within the cleft (17, 26, 27) . Therefore, the anesthetic actions of PB produced expectantly by the reduction in both unbinding and desensitizing rates as well as slowing the deactivation and the recovery from paired-pulse depression of the GlyR. These results provided a strong support for our conclusion that PB prolonged the glycinergic mIPSCs by slowing GlyR desensitization and Gly unbinding rate which leads to the prolongation of GlyR deactivation in spinal dorsal horn neurons. Thus, this study suggests that GlyR is an important target for not only volatile but also intravenous general anesthetic action.
Two Discrete Mechanisms of PB Modulation on GlyR-The present results show that PB reduced the peak amplitude of the Gly-induced current (I Gly ) and accelerated the I Gly macroscopic desensitization, and that the extent of the macroscopic desensitization increased with the rise of PB concentrations (Fig. 6B) . These effects may be caused by two mechanisms: one is the putative channel-blocking effect of PB and the other is allosteric modulation.
Previous studies have shown that barbiturates at concentrations over millimolar values can block GABA A R, leading to a reduced peak response (28 -30) . Molecular biological evidence has shown that GABA A R and GlyR belong to the same ligandgated ion channel protein superfamily (31) and that mutations of GlyR subunit (at two amino acid positions 159 and 161) render the receptor responsive to GABA (32), suggesting a close relationship between the two receptor systems. Thus, it is very likely that PB acts as an open-channel blocker on a block site of GlyR-Cl Ϫ channel complexes to accelerate the macroscopic desensitization of I Gly , similar to the effect of MK-801 on NMDA receptor-mediated current (33) (Fig. 11) . The presence of a tail (rebound) current after washout of agonists is a direct evidence for this hypothesis. After the washout of PB and Gly, the PB molecule binding to the block site was removed and the undesensitized GlyR might be re-activated by the agonist which did not have sufficient time to unbind, thereby producing the rebound current (Fig. 11 ). The rebound current was only induced by the removal of Gly and PB, and did not occur in the sequential application mode (Fig. 5) . Moreover, the removal of Gly and PB at a low concentration (0.03 mM) (Fig. 6A) did not induce the rebound current, indicating that the PB blockage is state-and concentration-dependent. The result of the voltage-dependence experiment (Fig. 4) is further in favor of such an open-channel block mechanism. The present experiments were performed at pH 7.4 at which 20% of PB is in anionic form (30) . When the membrane potential exceeded 0 mV, the driving force for anionic PB molecule was directed toward intracellular, leading to a potentiation of the blocking effect. The corollary is a more significant acceleration of macroscopic desensitization at positive holding potentials (Fig. 4) .
On the other hand, PB might allosterically modulate the function of GlyR, resulting in the slowness but not acceleration of GlyR desensitization. The result that the preperfusion of PB prior to the application of Gly caused the prolongation of the time constant of I Gly desensitization (Fig. 5Ac) indicated the possibility of PB slowing the GlyR desensitization in the absence of the blockage effect. On the other hand, no effect of low concentration PB on the amplitude of glycinergic mIPSC and the macroscopic desensitization of I Gly (Fig. 6 ) could be caused by the counteraction of the slight blockage effect and the allosterical modulation due to the low concentration of PB. According to several previous reports (34 -36) , the augmentation of the current noise during co-application of PB and Gly, or PB and taurine, which reflected channel opening with different conductance or opening probability, hinted that a modulation site of PB existed on GlyR. Moreover, the incomplete recovery of desensitization, which appeared in the wash traces (Figs. 4A and 6A) also indicates the effect of PB on the desensitization of GlyR. Due to the fact that the GlyR deactivation induced by low-potency agonist taurine mainly depends on agonist unbinding, the small effect of PB on GlyR deactivation after channel activation by taurine (Fig. 7) suggests that PB reduces the unbinding rate of Gly, leading to a slower deactivation of GlyR. With regard to the negligible effect of PB on macroscopic desensitization induced by taurine, a possible interpretation is that the rapid dissociation of taurine from GlyR impairs the action of PB. Therefore, although speculating, GlyR-Cl Ϫ channel complexes may contain not only block site(s) but also allosteric modulation site(s) (Fig. 11) , and in the presence of low concentrations of PB, allosteric modulation is dominant (Figs. 1  and 5) . Furthermore, the effect of preperfusion and the slow recovery of I Gly desensitization indicate that other mechanisms might contribute to the allosterical modulation of PB, which remain to be studied.
Comparison of GlyR and GABA A R Modulation-The anesthetic effect of barbiturates is thought to result, at least in part, from actions on GABA A Rs. Depending on the dose, PB has three effects on GABA A R. At low micromolar concentrations, PB potentiates the activation of GABA A R (37) . At high micromolar concentrations, PB directly gates the GABA A R (29, 30, (37) (38) (39) . At millimolar concentrations PB blocks the opening channels of GABA A R (29, 30, (37) (38) (39) . The actions appear to be mediated via different sites (39, 40) .
Similar to GABA A R, PB at high micromolar concentration (300 M) had a significant effect on the desensitization and deactivation of I Gly by modulating the gating of GlyR. However, the block effect of PB appeared synchronously, not needing to reach millimolar concentration, suggesting that PB may have a stronger block action on GlyR than that on GABA A R. Thus, similar to GABA A R, PB can act on at least two different sites of GlyR. Additionally, the present results clearly show that the peak amplitude of I Gly was reduced by PB at either low or high concentrations. Since there is evidence supporting that cotransmission between GABAergic and glycinergic transmitter systems may occur in the spinal dorsal horn (41) (42) (43) , the different effects of PB on GABA A R and GlyR would be functionally important. At clinical relevant concentrations, PB enhances the function of GABA A R, but reduces the I Gly . This would provide a mechanism for the modulation balance of PB, as a clinical anesthetic, between these two inhibitory transmitters.
With respect to the reduction of macroscopic peak current of I Gly induced by PB, the acceleration of macroscopic desensitization of I Gly cannot explain it fully due to the fact that PB (0.03 mM) inhibited the peak I Gly significantly but did not affect the current desensitization at all (Fig. 6B) . Also, the preperfusion effect of PB (Fig. 5Ac) and the result that the reduction of the peak I Gly was not voltage-dependent whereas the change of the desensitization was voltage-dependent ( Fig. 4C) suggest that the open-channel-block mechanism could not be the rational explanation. Moreover, the cross-inhibition between I Gly and GABA-induced response recently observed in the rat spinal dorsal horn neurons (43) was dependent on the agonist concentrations (44) , while the inhibition of the peak I Gly by PB was not Gly concentration-dependent (Fig. 2B) . Additionally, the effect of PB on I Gly is independent of the activation of GABA A R because BMI, the specific GABA A R antagonist, failed to alter the effects of PB on the peak and kinetics of I Gly (Fig. 9) . Thus the most likely explanation is the intracellular mechanisms and/or the lipid solubility. Additional experiments are needed to address the above mentioned possibilities.
In summary, PB acted on spinal GlyR allosterically modulating or blocking the I Gly , indicating that on GlyR both modulation and block site(s) may exist (Fig. 11) . The results presented herein provide evidence at the cellular level for the anesthetic action of general anesthetic on inhibitory receptor in spinal cord neurons. The functional change of spinal glycinergic neurotransmission in the presence of anesthetic may, at least in part, contribute to produce anesthesia. FIG. 11 . A possible modulation mechanism of PB on GlyR. 1, the GlyR channel closes before binding the ligand; 2, the binding of Gly and PB on GlyR leading to the channel opening allows a large amount of Cl Ϫ to flux intracellularly. Subsequently, GlyR desensitizes, resulting in the decrease of Cl Ϫ flux. 3, a PB molecule blocks the opening channel, which accelerates the macroscopic desensitization of I Gly . In this case, only a small amount of Cl Ϫ can pass through the channel. 4, the PB molecule is removed, and the channel reopens which increases the Cl Ϫ flux. 5, the agonist, Gly, and the modulator, PB, are removed, resulting in the closure of GlyR channel and the deactivation of I Gly . The thickness of the line with arrowhead reflects the amount of Cl Ϫ flux.
